APA (7th ed.) Citation

Utsunomiya, K., Koshida, R., Kakiuchi, S., Senda, M., Fujii, S., Kurihara, Y., . . . Kaku, K. (2021). Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real‐world clinical practice: Results of a 36‐month post‐marketing surveillance study (J‐STEP/LT). Wiley.

Chicago Style (17th ed.) Citation

Utsunomiya, Kazunori, Ryusuke Koshida, Seigo Kakiuchi, Masayuki Senda, Shoko Fujii, Yuji Kurihara, Ryoji Gunji, and Kohei Kaku. Safety and Effectiveness of Tofogliflozin in Japanese Patients with Type 2 Diabetes Mellitus Treated in Real‐world Clinical Practice: Results of a 36‐month Post‐marketing Surveillance Study (J‐STEP/LT). Wiley, 2021.

MLA (8th ed.) Citation

Utsunomiya, Kazunori, et al. Safety and Effectiveness of Tofogliflozin in Japanese Patients with Type 2 Diabetes Mellitus Treated in Real‐world Clinical Practice: Results of a 36‐month Post‐marketing Surveillance Study (J‐STEP/LT). Wiley, 2021.